glp-1 market news november 2025 ISPOR 2025: Exploring reasons for discontinuation GLP-1 Market Size to Hit

Coverage can vary widely depending on an individuals employer, plan type, and state regulations

According to the SmPC, nausea is very common (affecting approximately 44% of patients), while vomiting, diarrhoea, constipation, and abdominal pain are common side effects

Were going to deep-dive into the physiological differences that matter when selecting injection sites, how and when to rotate them, plus debunk some misinformation about the process

Dry your hands with a paper towel, and use the paper towel to turn off the faucet and open the door if needed

And, most recently, an analysis of the electronic health records of 817,309 patients with a history of AUD from January 2014 to August 2022 found that those taking GLP-1s experienced lower rates of alcohol intoxication

Available from: World Health Organization